158 related articles for article (PubMed ID: 37525754)
1. The Prognostic Value of the Age-Adjusted Charlson Comorbidity Index Among the Elderly with Breast Cancer.
Wang Z; Zhong Y; Zhou Y; Mao F; Zhang X; Wang C; Sun Q
Clin Interv Aging; 2023; 18():1163-1174. PubMed ID: 37525754
[TBL] [Abstract][Full Text] [Related]
2. The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients.
Di Donato V; Page Z; Bracchi C; Tomao F; Musella A; Perniola G; Panici PB
J Gynecol Oncol; 2019 Jan; 30(1):e6. PubMed ID: 30479090
[TBL] [Abstract][Full Text] [Related]
3. The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients.
Zhou S; Zhang XH; Zhang Y; Gong G; Yang X; Wan WH
Cancer Manag Res; 2022; 14():1683-1691. PubMed ID: 35573259
[TBL] [Abstract][Full Text] [Related]
4. Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities.
Telli TA; Alan O; Demircan NC; Sariyar N; Arikan R; Basoglu T; Yasar A; Celebi A; Isik S; Sofulu O; Erol B; Turkoz HK; Ozgen Z; Ercelep O; Dane F; Yumuk PF
Orthop Traumatol Surg Res; 2023 May; 109(3):103491. PubMed ID: 36455864
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of age-adjusted Charlson comorbidity index in laparoscopic resection for hilar cholangiocarcinoma.
Cai C; Tao L; Li D; Wang L; Xiao E; Luo G; Yan Z; Wang Y; Li D
Scand J Gastroenterol; 2024 Mar; 59(3):333-343. PubMed ID: 38018772
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of the age-adjusted Charlson comorbidity index in patients over 60 years old with laryngeal squamous cell carcinoma].
Li ZL; An CM; Gao ZH; Cao JZ; Huangfu H; Nan J; Zhu BY; Zhang Y
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Aug; 56(8):837-843. PubMed ID: 34521168
[No Abstract] [Full Text] [Related]
7. Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy.
Fink CA; Weykamp F; Adeberg S; Bozorgmehr F; Christopoulos P; Lang K; König L; Hörner-Rieber J; Thomas M; Steins M; El-Shafie RA; Rieken S; Bernhardt D; Debus J
Clin Transl Radiat Oncol; 2023 Sep; 42():100665. PubMed ID: 37564923
[TBL] [Abstract][Full Text] [Related]
8. Age-adjusted Charlson Comorbidity Index as a prognostic factor for radical prostatectomy outcomes of very high-risk prostate cancer patients.
Park JW; Koh DH; Jang WS; Lee JY; Cho KS; Ham WS; Rha KH; Jung WH; Hong SJ; Choi YD
PLoS One; 2018; 13(6):e0199365. PubMed ID: 29924851
[TBL] [Abstract][Full Text] [Related]
9. Association of high-risk comorbidity with overall survival among patients with gastric cancer and its sex-specific differences in China: a retrospective observational cohort study.
Wu J; Tian S; Xu J; Cheng N; Chen X; Yin J; Nie Z
BMC Cancer; 2023 Sep; 23(1):916. PubMed ID: 37770842
[TBL] [Abstract][Full Text] [Related]
10. Development of a model based on the age-adjusted Charlson comorbidity index to predict survival for resected perihilar cholangiocarcinoma.
Pan Y; Liu ZP; Dai HS; Chen WY; Luo Y; Wang YZ; Gao SY; Wang ZR; Dong JL; Liu YH; Yin XY; Liu XC; Fan HN; Bai J; Jiang Y; Cheng JJ; Zhang YQ; Chen ZY
World J Gastrointest Oncol; 2023 Jun; 15(6):1036-1050. PubMed ID: 37389112
[TBL] [Abstract][Full Text] [Related]
11. Age-adjusted Charlson comorbidity index is a significant prognostic factor for long-term survival of patients with high-risk prostate cancer after radical prostatectomy: a Bayesian model averaging approach.
Lee JY; Kang HW; Rha KH; Cho NH; Choi YD; Hong SJ; Cho KS
J Cancer Res Clin Oncol; 2016 Apr; 142(4):849-58. PubMed ID: 26660495
[TBL] [Abstract][Full Text] [Related]
12. The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who receive curative resection followed by adjuvant chemotherapy.
Aoyama T; Yamamoto N; Kamiya M; Murakawa M; Tamagawa H; Sawazaki S; Numata M; Kobayashi S; Ueno M; Morimoto M; Shiozawa M; Yukawa N; Oshima T; Yoshikawa T; Rino Y; Masuda M; Morinaga S
J Cancer Res Ther; 2020 Dec; 16(Supplement):S116-S121. PubMed ID: 33380664
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of the Age-Adjusted Charlson Comorbidity Index (ACCI) on Short- and Long-Term Outcome in Patients with Advanced Primary Epithelial Ovarian Cancer.
Kahl A; du Bois A; Harter P; Prader S; Schneider S; Heitz F; Traut A; Alesina PF; Meier B; Walz M; Brueckner A; Groeben HT; Brunkhorst V; Heikaus S; Ataseven B
Ann Surg Oncol; 2017 Nov; 24(12):3692-3699. PubMed ID: 28871563
[TBL] [Abstract][Full Text] [Related]
14. Comorbidity indexing for prediction of the clinical outcome after stereotactic body radiation therapy in non-small cell lung cancer.
Dreyer J; Bremer M; Henkenberens C
Radiat Oncol; 2018 Nov; 13(1):213. PubMed ID: 30390700
[TBL] [Abstract][Full Text] [Related]
15. Effect of the Age-Adjusted Charlson Comorbidity Index on the Survival of Esophageal Squamous Cell Carcinoma Patients after Radical Esophagectomy.
Song J; Lin Y; Zhang J; Liu S; Zhou J; Zeng Q; Lin Z; Fu R; Qiu M; Hu Z
J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431214
[TBL] [Abstract][Full Text] [Related]
16. Age-adjusted Charlson Comorbidity Index predicts prognosis of laryngopharyngeal cancer treated with radiation therapy.
Takemura K; Takenaka Y; Ashida N; Shimizu K; Oya R; Kitamura T; Yamamoto Y; Uno A
Acta Otolaryngol; 2017 Dec; 137(12):1307-1312. PubMed ID: 28875745
[TBL] [Abstract][Full Text] [Related]
17. Age-adjusted Charlson comorbidity index as a prognostic factor of hypopharyngeal cancer treated with chemoradiation therapy.
Tanaka H; Takenaka Y; Nakahara S; Hanamoto A; Fukusumi T; Michiba T; Takemoto N; Cho H; Yamamoto M; Yamamoto Y; Inohara H
Acta Otolaryngol; 2017 Jun; 137(6):668-673. PubMed ID: 28084858
[TBL] [Abstract][Full Text] [Related]
18. Age-adjusted charlson comorbidity index score as predictor of prolonged postoperative ileus in patients with colorectal cancer who underwent surgical resection.
Tian Y; Xu B; Yu G; Li Y; Liu H
Oncotarget; 2017 Mar; 8(13):20794-20801. PubMed ID: 28206969
[TBL] [Abstract][Full Text] [Related]
19. Association of the age-adjusted Charlson Comorbidity Index and systemic inflammation with survival in gastric cancer patients after radical gastrectomy.
Lin JX; Huang YQ; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Huang ZN; Lin JL; Zheng CH; Huang CM; Li P
Eur J Surg Oncol; 2019 Dec; 45(12):2465-2472. PubMed ID: 31350072
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer.
Suidan RS; Leitao MM; Zivanovic O; Gardner GJ; Long Roche KC; Sonoda Y; Levine DA; Jewell EL; Brown CL; Abu-Rustum NR; Charlson ME; Chi DS
Gynecol Oncol; 2015 Aug; 138(2):246-51. PubMed ID: 26037900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
